GRFS (Grifois, S.A.) Stock Analysis - Analyst Ratings

Grifois, S.A. (GRFS) is a publicly traded Healthcare sector company. As of May 21, 2026, GRFS trades at $8.20 with a market cap of $5.36B and a P/E ratio of 0.00. GRFS moved +4.46% today. Year to date, GRFS is -12.12%; over the trailing twelve months it is +1.87%. Its 52-week range spans $6.19 to $11.14. Rallies surfaces GRFS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate GRFS?

The average price target is $0.00.

GRFS Key Metrics

Key financial metrics for GRFS
MetricValue
Price$8.20
Market Cap$5.36B
P/E Ratio0.00
EPS$0.00
Dividend Yield0.16%
52-Week High$11.14
52-Week Low$6.19
Volume4
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

GRFS Analyst Consensus

GRFS analyst coverage data. Average price target: $0.00.

Latest GRFS News

Common questions about GRFS

What do analysts rate GRFS?
The average price target is $0.00.
Does Rallies show GRFS price targets?
Yes. Rallies tracks GRFS analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is GRFS research on Rallies investment advice?
No. Rallies provides research, data, and educational context for GRFS. It does not provide personalized investment advice.
GRFS

GRFS